These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3311748)

  • 1. A structural and dynamic model for the nicotinic acetylcholine receptor.
    Kosower EM
    Eur J Biochem; 1987 Oct; 168(2):431-49. PubMed ID: 3311748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A structural and dynamic model for the nicotinic acetylcholine receptor.
    Kosower EM
    Prog Clin Biol Res; 1989; 289():279-92. PubMed ID: 2471206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [(3)H]chlorpromazine photolabeling of the torpedo nicotinic acetylcholine receptor identifies two state-dependent binding sites in the ion channel.
    Chiara DC; Hamouda AK; Ziebell MR; Mejia LA; Garcia G; Cohen JB
    Biochemistry; 2009 Oct; 48(42):10066-77. PubMed ID: 19754159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface.
    Blanton MP; Xie Y; Dangott LJ; Cohen JB
    Mol Pharmacol; 1999 Feb; 55(2):269-78. PubMed ID: 9927618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ion channel of the nicotinic acetylcholine receptor is formed by the homologous helices M II of the receptor subunits.
    Hucho F; Oberthür W; Lottspeich F
    FEBS Lett; 1986 Sep; 205(1):137-42. PubMed ID: 2427361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncompetitive antagonist binding sites in the torpedo nicotinic acetylcholine receptor ion channel. Structure-activity relationship studies using adamantane derivatives.
    Arias HR; Trudell JR; Bayer EZ; Hester B; McCardy EA; Blanton MP
    Biochemistry; 2003 Jun; 42(24):7358-70. PubMed ID: 12809491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors.
    Arias HR; Bhumireddy P; Spitzmaul G; Trudell JR; Bouzat C
    Biochemistry; 2006 Feb; 45(7):2014-26. PubMed ID: 16475790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]Benzophenone photolabeling identifies state-dependent changes in nicotinic acetylcholine receptor structure.
    Garcia G; Chiara DC; Nirthanan S; Hamouda AK; Stewart DS; Cohen JB
    Biochemistry; 2007 Sep; 46(36):10296-307. PubMed ID: 17685589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.
    Arias HR
    Biochim Biophys Acta; 1998 Aug; 1376(2):173-220. PubMed ID: 9748559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the structure of the affinity-purified and lipid-reconstituted torpedo nicotinic acetylcholine receptor.
    Hamouda AK; Chiara DC; Blanton MP; Cohen JB
    Biochemistry; 2008 Dec; 47(48):12787-94. PubMed ID: 18991407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural organization of nicotinic acetylcholine receptors.
    Utkin YuN ; Tsetlin VI; Hucho F
    Membr Cell Biol; 2000; 13(2):143-64. PubMed ID: 10779169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrangement of the acetylcholine receptor subunits in the resting and desensitized states, determined by cryoelectron microscopy of crystallized Torpedo postsynaptic membranes.
    Unwin N; Toyoshima C; Kubalek E
    J Cell Biol; 1988 Sep; 107(3):1123-38. PubMed ID: 3417777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist-induced photoincorporation of a p-benzoylphenylalanine derivative of substance P into membrane-spanning region 2 of the Torpedo nicotinic acetylcholine receptor delta subunit.
    Blanton MP; Li YM; Stimson ER; Maggio JE; Cohen JB
    Mol Pharmacol; 1994 Dec; 46(6):1048-55. PubMed ID: 7528876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of a cholinergic binding site by means of synthetic peptides, monoclonal antibodies, and alpha-bungarotoxin.
    Conti-Tronconi BM; Tang F; Diethelm BM; Spencer SR; Reinhardt-Maelicke S; Maelicke A
    Biochemistry; 1990 Jul; 29(26):6221-30. PubMed ID: 2207067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional domains of the nicotinic acetylcholine receptor.
    Karlin A; Cox RN; Dipaola M; Holtzman E; Kao PN; Lobel P; Wang L; Yodh N
    Ann N Y Acad Sci; 1986; 463():53-69. PubMed ID: 3521435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the noncompetitive antagonist-binding site in the ion channel of the nicotinic acetylcholine receptor in the resting state.
    Blanton MP; McCardy EA; Gallagher MJ
    J Biol Chem; 2000 Feb; 275(5):3469-78. PubMed ID: 10652341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging three-dimensional structure of a receptor. The nicotinic acetylcholine receptor.
    Hucho F; Tsetlin VI; Machold J
    Eur J Biochem; 1996 Aug; 239(3):539-57. PubMed ID: 8774696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photolabeling of membrane-bound Torpedo nicotinic acetylcholine receptor with the hydrophobic probe 3-trifluoromethyl-3-(m-[125I]iodophenyl)diazirine.
    White BH; Cohen JB
    Biochemistry; 1988 Nov; 27(24):8741-51. PubMed ID: 3242605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the binding site(s) for antidepressants on the Torpedo nicotinic acetylcholine receptor: [3H]2-azidoimipramine photolabeling and molecular dynamics studies.
    Sanghvi M; Hamouda AK; Jozwiak K; Blanton MP; Trudell JR; Arias HR
    Biochim Biophys Acta; 2008 Dec; 1778(12):2690-9. PubMed ID: 18817747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
    Arias HR; Ortells MO; Feuerbach D
    Neurochem Int; 2013 Nov; 63(5):423-31. PubMed ID: 23917086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.